INmune Bio receives MHRA pediatric plan approval for Ebstrocel

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to INmune Bio receives MHRA pediatric plan approval for Ebstrocel
(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High $ 
Open $2.22    52 Week Low $ 
Day High $2.40    P/E N/A 
Day Low $2.21    EPS $ 
Volume 677,642